AdhereTech, a New York, NY-based healthcare technology company that makes patented smart pill bottles to improve medication adherence and patient engagement, closed $1.75m in Series A financing.
The round was led by undisclosed investors with a focus on healthcare.
The company intends to use the funds to scale its service.
Led by CEO Josh Stein, AdhereTech has developed patented intelligent pill bottles built with cellular technology and numerous sensors. The devices automatically send adherence data to the compny’s servers, where analysis occurs in real-time. If a dose is missed, the system reminds the patient via automated phone call or text message – as well as on-bottle lights and chimes. If the system notices prolonged non-adherence, it can solicit feedback from patients via text or phone call to understand the reasons for non-adherence, and intervene accordingly.
AdhereTech is a member of the StartUp Health and GE Entrepreneurship Program, and is a graduate of the Blueprint Health accelerator.